Expression and clinical significance of vascular endothelial growth factor, cyclooxygenase-2, and Bcl-2 in borderline ovarian tumors

Archives of Gynecology and Obstetrics

Volumn 272, Issue 1, 2005, Pages 48-52

  Li, Min ^a   Qi, Shu Ying ^a   Wang, Yong ^a   Feng, Shu Xian ^a   Zhang, Bang Zhi ^b   Wang, Rui ^b  

^a LANZHOU MEDICAL COLLEGE   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

Bcl 2; Borderline ovarian tumor; Cyclooxygenase 2; Immunohistochemical; Vascular endothelial growth factor

Indexed keywords

CYCLOOXYGENASE 2; PROTEIN BCL 2; VASCULOTROPIN;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVARY TUMOR; PERITONEUM; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR DIAGNOSIS;

CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 21244451552     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-004-0708-9     Document Type: Article

References (32)

1. Smith WL, Garavito RM, DeWitt DL (1996) Prostaglandin endoperoxide H synthases (cyclooxygenase)-1 and -2. J Biol Chem 271:33157-33160
2. Vane J (1994) Towards a better aspirin. Nature 367:215-216
3. Eberhart CE, Dubois RN (1995) Eicosanoids and the gastrointestinal tract. Gastroenterology 109:285-301
4. Shi H, Xu JM, Hu NZ, Xie HJ (2003) Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. World J Gastroenterol 9:1421-1426
5. Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Worener BM, Koki A, Fahey TJ (1999) Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 59:987-990
6. Hwang D, Scollard D, Byrne J, Levine E (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90:455-460
7. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A (1998) Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58:4997-5001
8. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875-1887
9. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039
10. Song ZJ, Gong P, Wu YE (2002) Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 8:591-595
11. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6
12. Kim HS, Youm HR, Lee JS, Min KW, Chung JH, Park CS (2003) Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer. Lung Cancer 42:163-170
13. Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Ciampi B, Prontera C, Genazzani AR (1999) Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome. Anticancer Res 19:1401-1405
14. Tao HQ, Lin YZ, Wang RN (1998) Significance of vascular endothelial growth factor messenger RNA expression in gastric cancer. World J Gastroenterol 4:10-13
15. Wyllie AH (1995) The genetic regulation of apoptosis. Curr Opin Genet Dev 5:97-104
16. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6
17. Kitagawa Y, Wong F, Lo P, Elliott M, Verburgt LM, Hogg JC, Daya M (1996) Overexpression of bcl-2 and mutation in p53 and K-ras in resected human non-small-cell lung cancers. Am J Respir Cell Mol Biol 15:45-54
18. Parenti AR, Rugge M, Shiao YH, Ruol A, Ancona E, Bozzola L, Ninfo V (1997) Bcl-2 and p53 immunophenotypes in premalignant, early and advanced esophageal squamous cancer. Histopathology 31:430-435
19. Wikonkal NM, Berg RJ, van Haselen CW, Horkay I, Remenyik E, Begany A, Hunyadi J, van Vloten WA, de Gruijl FR (1997) Bcl-2 versus p53 protein expression and apoptotic rate in human nonmelanoma skin cancers. Arch Dermatol 133:599-602
20. Hori M, Nogami T, Itabashi M, Yoshimi F, Ono H, Koizumi S (1997) Expression of bcl-2 in human breast cancer: correlation between hormone receptor status, p53 protein accumulation and DNA strand breaks associated with apoptosis. Pathol Int 47:757-762
21. Gately S (2000) The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 19:19-27
22. International Federation of Gynecology and Obstetrics (1987) Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 156:246
23. Leung DW, Cachianes G, Kuang WJ, Goedel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309
24. Trefan OC, Hla T (2003) Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med 7:207-222
25. Murata H, Kawano S, Tsuji S, Tsuji M, Sawaoka H, Kimura Y, Shiozaki H, Hori M (1999) Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 94:451-455
26. Ohno R, Yoshinaga K, Fujita T, Hasegawa K, Iseki H, Tasunozaki H, Ichikawa W, Nihei Z, Sugihara K (2001) Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 91:1876-1881
27. McConkey DJ, Chandra J, Wright S, Plunkett W, McDonnell TJ, Reed JC, Keating M (1996) Apoptosis sensitivity in chronic lymphocytic leukaemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J Immunol 156:2624-2630
28. Henriksen R, Wilander E, Oberg K (1995) Expression and prognostic significance of Bcl-2 in ovarian tumors. Br J Cancer 72:1324-1329
29. Chan WY, Cheung KK, Schouge JO, Huang LW, Welch WR, Bell DA, Berkowitz RS, Mok SC (2000) Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol 156:409-417
30. Chan WY, Yew DT (1998) Apoptosis and bcl-2 oncoprotein expression in the human fetal central nervous system. Anat Rec 252:165-175
31. Novak VD, Korsmeyer SJ (1994) Protein expression during murine development. Am J Pathol 145:61-73
32. Fosslien E (2001) Molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci 31:325-348